JP2026035742A5 - - Google Patents
Info
- Publication number
- JP2026035742A5 JP2026035742A5 JP2025209848A JP2025209848A JP2026035742A5 JP 2026035742 A5 JP2026035742 A5 JP 2026035742A5 JP 2025209848 A JP2025209848 A JP 2025209848A JP 2025209848 A JP2025209848 A JP 2025209848A JP 2026035742 A5 JP2026035742 A5 JP 2026035742A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- fusion protein
- polypeptide chain
- protein according
- terminus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010393721.9 | 2020-05-11 | ||
| CN202010393721.9A CN113637084B (zh) | 2020-05-11 | 2020-05-11 | 生物大分子靶向特异性补体抑制剂及其制备方法与应用 |
| PCT/CN2021/092861 WO2021228052A1 (zh) | 2020-05-11 | 2021-05-10 | 生物大分子靶向特异性补体抑制剂及其制备方法与应用 |
| JP2022568638A JP7834347B2 (ja) | 2020-05-11 | 2021-05-10 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568638A Division JP7834347B2 (ja) | 2020-05-11 | 2021-05-10 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026035742A JP2026035742A (ja) | 2026-03-04 |
| JP2026035742A5 true JP2026035742A5 (cg-RX-API-DMAC7.html) | 2026-03-31 |
Family
ID=78415417
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568638A Active JP7834347B2 (ja) | 2020-05-11 | 2021-05-10 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
| JP2025209848A Pending JP2026035742A (ja) | 2020-05-11 | 2025-11-28 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568638A Active JP7834347B2 (ja) | 2020-05-11 | 2021-05-10 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230348554A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4151659A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7834347B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN113637084B (cg-RX-API-DMAC7.html) |
| CA (1) | CA3178088A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021228052A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7560185B2 (ja) * | 2020-07-07 | 2024-10-02 | カナプ セラピューティクス インコーポレイテッド | 補体経路阻害剤及び血管新生阻害剤を含む融合タンパク質並びにその使用 |
| CN114920849A (zh) * | 2022-03-09 | 2022-08-19 | 安徽省立医院(中国科学技术大学附属第一医院) | 一种靶向补体免疫抑制蛋白及其构建方法及应用 |
| KR20260108593A (ko) * | 2023-11-13 | 2026-07-08 | 선양 선샤인 파마슈티컬 씨오 엘티디 | C3b 표적 이중기능성 융합 단백질, 이의 제조방법 및 용도 |
| CN121159642B (zh) * | 2025-11-20 | 2026-04-03 | 山东第二医科大学 | 补体c9迷你结合蛋白或其突变体及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8088386B2 (en) * | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
| AU2009303526B2 (en) * | 2008-10-14 | 2015-01-15 | Genentech, Inc. | Immunoglobulin variants and uses thereof |
| CN104231085B (zh) * | 2013-09-05 | 2017-03-15 | 复旦大学附属肿瘤医院 | 靶向特异性补体系统抑制剂、其制备方法及应用 |
| WO2017114401A1 (zh) * | 2015-12-31 | 2017-07-06 | 江苏匡亚生物医药科技有限公司 | 具有补体调节活性的重组补体因子h-免疫球蛋白融合蛋白及其制备方法与应用 |
| KR102715492B1 (ko) | 2017-10-18 | 2024-10-11 | 씨에스엘 리미티드 | 인간 혈청 알부민 변이체 및 이의 용도 |
| CN112118859A (zh) | 2018-05-16 | 2020-12-22 | 杰特有限公司 | 1型可溶性补体受体变体及其用途 |
| WO2020041644A1 (en) * | 2018-08-22 | 2020-02-27 | Alexion Pharmaceuticals, Inc. | Fusion proteins and methods of treating complement dysregulation using the same |
| CN111018999B (zh) * | 2019-12-05 | 2022-07-12 | 沣潮医药科技(上海)有限公司 | 二聚体免疫融合蛋白、药物组合物和用途 |
-
2020
- 2020-05-11 CN CN202010393721.9A patent/CN113637084B/zh active Active
-
2021
- 2021-05-10 CA CA3178088A patent/CA3178088A1/en active Pending
- 2021-05-10 WO PCT/CN2021/092861 patent/WO2021228052A1/zh not_active Ceased
- 2021-05-10 CN CN202180034009.2A patent/CN115515985A/zh active Pending
- 2021-05-10 US US17/998,367 patent/US20230348554A1/en active Pending
- 2021-05-10 JP JP2022568638A patent/JP7834347B2/ja active Active
- 2021-05-10 EP EP21804660.5A patent/EP4151659A4/en active Pending
-
2025
- 2025-11-28 JP JP2025209848A patent/JP2026035742A/ja active Pending